Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
about
Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsToward single-walled carbon nanotube-gadolinium complex as advanced MRI contrast agents: pharmacodynamics and global genomic response in small animalsMRI contrast agents: basic chemistry and safety.Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentMultimodality imaging probes: design and challenges.MR imaging of articular cartilage physiology.Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.Integrin-mediated signaling contributes to gadolinium-containing-particle-promoted cell survival and G₁ to S phase cell cycle transition by enhancing focal adhesion formation.Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug deliveryResponses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum.Contrast-induced acute kidney injury and diabetic nephropathy.Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonanceSynthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.Cerebral perfusion changes in migraineurs: a voxelwise comparison of interictal dynamic susceptibility contrast MRI measurementsPathomechanisms of nephrogenic systemic fibrosis: new insights.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Synthesis and in vitro assessment of a bifunctional closomer probe for fluorine ((19)F) magnetic resonance and optical bimodal cellular imaging.Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents.Advanced MRI of articular cartilage.Understanding nephrogenic systemic fibrosisGadolinium promoted proliferation in mouse embryo fibroblast NIH3T3 cells through Rac and PI3K/Akt signaling pathways.Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach.Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.Analysis of gadolinium-based contrast agents in tap water with a new hydrophilic interaction chromatography (ZIC-cHILIC) hyphenated with inductively coupled plasma mass spectrometry.Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions.Synthesis, relaxation properties and in vivo assessment of a carborane-GdDOTA-monoamide conjugate as an MRI blood pool contrast agent.Biocompatibility of Gd-Loaded Chitosan-Hyaluronic Acid Nanogels as Contrast Agents for Magnetic Resonance Cancer Imaging.Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T1/T2 MRI contrast agents
P2860
Q27027613-E18F2E71-DCC9-49EA-836D-AE76FA19806AQ28391991-885B09C5-CF54-466B-AA5C-6D4D2A7E4842Q30574482-BF1AF4CE-158D-442B-B496-FBEE3C70E885Q30576125-6B9F4EAD-DBDF-4997-A72C-9FE07F64F49DQ33884695-8017A292-7EA1-4B57-B22A-BD5F0E79B629Q33930002-C60F7D12-EAEC-46F2-BC87-9DF82ED7B925Q34056490-7F1C507A-E2FB-4B2A-91C5-8B62C0BEDB16Q34075193-B2F49DC4-4489-4D74-94C7-B9E16D2D501AQ34441150-EA566487-D8DD-450D-95A1-118B61A7C878Q35187986-B45600BD-ACC7-4199-B7B0-AA918A8FCB4DQ35194954-553BD6FB-43C8-494D-92AC-2FB5267EB87AQ35766187-C2D9693C-82E7-48A0-9F0F-F90631BE26B7Q36130156-B85D78C7-053B-4311-925A-DFC04B59C00AQ36555396-A2D994AF-7D8F-44B8-85A3-8EFCA52DBC97Q37095231-55DBAC9B-9640-449F-AF63-1037FAD64C78Q37905890-67D4E571-01E9-4BED-8F97-2F230E7E3DEAQ38667169-9EDB6B48-BDDD-417D-9F16-BD252BAB2E98Q39001877-64DACE22-AEB4-441E-B2B8-EC3C5170A76BQ39302040-BE07A8E4-CD06-4F76-85BA-82FB2DEB4411Q39608425-10A798B4-EAA3-488B-AED9-5940280DBB5FQ41545279-2E6811BB-6629-467D-9981-52D92F420638Q42799384-9D882BE9-F5EE-44EF-9120-01CEBA80B27AQ45814502-64D0A0E7-E1D5-4E47-96F6-022D578BD82CQ46628940-4FD1644D-21B7-42C5-B975-952D9C21515CQ46801219-66AD078A-8C43-4F3E-837A-400268BA7936Q47553880-E902EF19-91C9-44CC-ABE0-7DFFB691CC84Q53411366-607E73F7-289D-4968-911B-CF8E46ADE263Q55080578-F4DD02FD-577F-4237-8F32-96F75718FDECQ57348100-80AC35D4-2416-43F0-9F92-F6B2DBD623AD
P2860
Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Possible involvement of gadoli ...... c fibrosis: a critical review.
@en
Possible involvement of gadoli ...... c fibrosis: a critical review.
@nl
type
label
Possible involvement of gadoli ...... c fibrosis: a critical review.
@en
Possible involvement of gadoli ...... c fibrosis: a critical review.
@nl
prefLabel
Possible involvement of gadoli ...... c fibrosis: a critical review.
@en
Possible involvement of gadoli ...... c fibrosis: a critical review.
@nl
P2093
P1433
P1476
Possible involvement of gadoli ...... c fibrosis: a critical review.
@en
P2093
Christelle Medina
Claire Corot
Emmanuelle Fayoux
Eric Lancelot
Jean-Marc Idée
Sébastien Ballet
P356
10.1016/J.TOX.2008.03.012
P407
P577
2008-03-22T00:00:00Z